---
title: "$NXG.V  is up 35% today after generating nearly the same net income in Q1 2026, as all of 2025.   This one is worth a look."
url: "https://www.readplaza.com/posts/nxgv-is-up-35-today-after-generating-nearly-the-same-net-income-in-q1-2026-as-all-of-2025-this-one-is-worth-a-look"
author: "LadsoMarkets (@LadsoMarkets)"
type: "discussion"
published: "2026-05-22T14:52:52.415+00:00"
updated: "2026-06-18T20:40:02.879701+00:00"
access: "public"
tags: ["Value Investing", "Healthcare", "Medium term", "Micro", "Canada", "Healthcare", "Value Investing", "Micro Cap", "Medium term", "Canada", "Equities", "Dividend Investing", "Fundamental Analysis", "Stock Analysis", "Penny Stocks"]
---

# $NXG.V  is up 35% today after generating nearly the same net income in Q1 2026, as all of 2025.   This one is worth a look.

<p>NexgenRx processes drug and dental claims for Canadian employers and charges a small fee every time a claim runs through their platform.</p><p>Q1 2026 net income: $1.23M. Full year 2025 net income: $1.29M.</p><p>Revenue up 12% YoY while total expenses actually fell.</p><p>The growth is being driven by Patient Support Programs, where drug manufacturers enroll patients and every claim runs through NXG's platform at a fee. That volume has been accelerating for multiple years.</p><p>They are basically Canada's only independent full-service third-party administrator in this space. The big insurers outsource claims adjudication, and NXG sits in that gap.</p><p>Profitable. Growing. Zero debt. Pays a dividend.</p><p>$30M market cap on a business doing nearly $18M in annual revenue and growing.</p><p>If Q1 pace holds, they could do $4-5M in net income in 2026 alone.</p><p>Insiders own 37% of shares.</p><p>Not financial advice in the slightest.</p>

## Author profile
LadsoMarkets (@LadsoMarkets)

Primary publisher: GoingToADollar

Stats: 6 posts, 4 followers, 2 following